← Back to headlines
Immunic Closes $200M Private Placement for MS Trials
Immunic has closed a $200 million private placement to fund late-stage multiple sclerosis trials, securing significant capital for its research and development.
17 Feb, 21:33 — 17 Feb, 21:33
Sources
Showing 1 of 1 sources
Related Stories
BOJ Deputy Governor Urges Timely Interest Rate Hike Amid Inflation Pressures
26m ago
European Renewable Firms Report Record Earnings and Battery Storage Expansions
32m ago
Asian Markets Show Mixed Gains as Nvidia Outlook Offsets Inflation Concerns
34m ago
Halfords Raises Profit Forecast on Warm Weather Sales Boost
35m ago